Toronto Dominion Bank’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
VCM
NCNMGF
SAM
KCM
FCM
RI
MBAM
Toronto Dominion Bank's XGN Position: Q1 2026 in Review
Toronto Dominion Bank sold out of Exagen (XGN) in Q1 2026, closing a stake of 20,029 shares — an estimated $122K sold.
Toronto Dominion Bank first reported a position in XGN in Q4 2024 and held it in 5 quarters. The position peaked at $5.94M in Q2 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- Toronto Dominion Bank reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
- Toronto Dominion Bank sold 20,029 Exagen shares in Q1 2026, an estimated $122K.
- Toronto Dominion Bank first reported a position in Exagen in Q4 2024 and held it in 5 quarters.
- Toronto Dominion Bank's Exagen position peaked at $5.94M in Q2 2025.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.